Eli Lilly Company Gets CDSCO Panel Nod To Import, Market Antidiabetic drug Tirzepatide for chronic weight management Dr. Divya Colin3 July 2024 6:00 PM ISTNew Delhi: The drug major Eli Lily Company India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Novel GLP-1/GIP receptor agonist effective for chronic weight management Jacinthlyn Sylvia5 March 2024 5:00 AM ISTViking Therapeutics has unveiled compelling Phase 2 data for their dual GLP-1/GIP receptor agonist, VK2735 for chronic weight management. The VENTURE...
FDA approves injection Tirzepatide for chronic weight management Dr. Kamal Kant Kohli9 Nov 2023 11:45 AM ISTThe US Food And Drug Administration has approved injection tirzepatide (Zepbound) for weight management in adults on long term basis. Tirzepatide...
Higher dosage of oral semaglutide useful for chronic weight management and glycemic control Aditi30 Jun 2023 8:15 AM ISTNew indications could be on the horizon for oral semaglutide based on data from OASIS-1 and PIONEER PLUS trials. Presented at the 83rd Scientific...
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 Hina Zahid7 Jun 2021 7:30 AM ISTToday, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with...
